# Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis

> clinical trial · VERIFIED · 2026-08-26

Status: RECRUITING · Sponsor: Douglas Mental Health University Institute · Condition: Clinical High Risk for Psychosis (CHR)

- Company: Douglas Mental Health University Institute
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT07786714

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.